AMAG Pharma (AMAG) Posts Q1 Loss of $1.06, Sales Miss Views
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q1 EPS of ($1.06), which may not compare to the analyst estimate of $1.64. Revenue for the quarter came in at $140.8 million versus the consensus estimate of $152.35 million.
GUIDANCE:
AMAG Pharma sees FY2017 revenue of $625-685 million, versus the consensus of $644.23 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
